IL-6 in inflammation, autoimmunity and cancer

T Hirano - International immunology, 2021 - academic.oup.com
IL-6 is involved both in immune responses and in inflammation, hematopoiesis, bone
metabolism and embryonic development. IL-6 plays roles in chronic inflammation (closely …

Constitutive activation of STAT 3 in breast cancer cells: A review

K Banerjee, H Resat - International journal of cancer, 2016 - Wiley Online Library
Signal transducer and activator of transcription 3 (STAT3) is constitutively activated in
numerous cancer types, including more than 40% of breast cancers. In contrast to tight …

[HTML][HTML] Cancer stem cell secretome in the tumor microenvironment: a key point for an effective personalized cancer treatment

J López de Andrés, C Griñán-Lisón, G Jiménez… - Journal of hematology & …, 2020 - Springer
Cancer stem cells (CSCs) represent a tumor subpopulation responsible for tumor metastasis
and resistance to chemo-and radiotherapy, ultimately leading to tumor relapse. As a …

Interleukin-6 signaling pathway in targeted therapy for cancer

Y Guo, F Xu, TJ Lu, Z Duan, Z Zhang - Cancer treatment reviews, 2012 - Elsevier
Interleukin-6 (IL-6) is a multifunctional cytokine which plays an important role in a wide
range of biologic activities in different types of cell including tumor cells. IL-6 is involved in …

The IL-6/JAK/Stat3 feed-forward loop drives tumorigenesis and metastasis

Q Chang, E Bournazou, P Sansone, M Berishaj… - Neoplasia, 2013 - Elsevier
We have investigated the importance of interleukin-6 (IL-6) in promoting tumor growth and
metastasis. In human primary breast cancers, increased levels of IL-6 were found at the …

The pleiotropic role of transcription factor STAT3 in oncogenesis and its targeting through natural products for cancer prevention and therapy

M Garg, MK Shanmugam, V Bhardwaj… - Medicinal research …, 2021 - Wiley Online Library
Signal transducer and activator of transcription 3 (STAT3) is one of the crucial transcription
factors, responsible for regulating cellular proliferation, cellular differentiation, migration …

[HTML][HTML] Activation of an IL6 inflammatory loop mediates trastuzumab resistance in HER2+ breast cancer by expanding the cancer stem cell population

H Korkaya, G Kim, A Davis, F Malik, NL Henry… - Molecular cell, 2012 - cell.com
Although inactivation of the PTEN gene has been implicated in the development of
resistance to the HER2 targeting antibody trastuzumab, the mechanisms mediating this …

Growth of triple-negative breast cancer cells relies upon coordinate autocrine expression of the proinflammatory cytokines IL-6 and IL-8

ZC Hartman, GM Poage, P Den Hollander, A Tsimelzon… - Cancer research, 2013 - AACR
Triple-negative breast cancers (TNBC) are aggressive with no effective targeted therapies. A
combined database analysis identified 32 inflammation-related genes differentially …

[HTML][HTML] Resistance to trastuzumab

S Vivekanandhan, KL Knutson - Cancers, 2022 - mdpi.com
Simple Summary Trastuzumab is a humanized antibody that has significantly improved the
management and treatment outcomes of patients with cancers that overexpress HER2 …

[HTML][HTML] Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3 …

SA Ibrahim, R Gadalla, EA El-Ghonaimy, O Samir… - Molecular cancer, 2017 - Springer
Background Inflammatory breast cancer (IBC), a particularly aggressive form of breast
cancer, is characterized by cancer stem cell (CSC) phenotype. Due to a lack of targeted …